Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy

MLA

Liza Svoboda, et al. “Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy.” Ophthalmology, vol. 124, June 2017, pp. 776–85. EBSCOhost, https://doi.org/10.1016/j.ophtha.2017.01.036.

APA

Liza Svoboda, Giovanni Staurenghi, Louis Alpern, Guadalupe Cervantes-Coste Cervantes, Alexis Tsorbatzoglou, Glenn J. Jaffe, Adeniyi Adewale, Rishi P Singh, Robert Lehmann, Ayala Pollack, Joseph N. Martel, Kevin Jong, & Satish S. Modi. (2017). Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy. Ophthalmology, 124, 776–785. https://doi.org/10.1016/j.ophtha.2017.01.036

Chicago

Liza Svoboda, Giovanni Staurenghi, Louis Alpern, Guadalupe Cervantes-Coste Cervantes, Alexis Tsorbatzoglou, Glenn J. Jaffe, Adeniyi Adewale, et al. 2017. “Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy.” Ophthalmology 124 (June): 776–85. doi:10.1016/j.ophtha.2017.01.036.